ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #1,790HybridDomestic Journal

Genes & Diseases

Acronym:gendis
•
Abbreviation (ISO):GENES DIS
•
Identifier (ISSN):2352-4820(Print)/2352-3042(Online)
•
Publisher:ELSEVIER
Clarivate IF (2026)
14.6↑ +5.2
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2020–2026)

Clarivate IF trend for Genes & Diseases

WoS Q1
3814194.820207.120217.2420226.820236.920249.4202514.62026
Annual Impact Factor Metric
Current (2026):14.6
Scopus SJR & RankScopus Q1
1.776
#1,790

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
77

77 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation Rate2.9%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
110articles/year
98.09% Gold OA•55.77% Original Research

Aims & Scope

Genes & Diseases is an international journal for molecular and translational medicine. The journal primarily focuses on publishing investigations on the molecular bases and experimental therapeutics of human diseases. Publication formats include full length research article, review article, short communication, correspondence, perspectives, commentary, views on news, and research watch. Aims and Scopes Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the molecular bases of human diseases. Emphasis will be placed on hypothesis-driven, mechanistic studies relevant to pathogenesis and/or experimental therapeutics of human diseases. The journal has worldwide authorship, and a broad scope in basic and translational biomedical research of molecular biology, molecular genetics, and cell biology, including but not limited to cell proliferation and apoptosis, signal transduction, stem cell biology, developmental biology, gene regulation and epigenetics, cancer biology, immunity and infection, neuroscience, disease-specific animal models, gene and cell-based therapies, and regenerative medicine.

Topics Covered (Recognized by AI)
Biology99.1%Genetics95.6%Medicine90.6%Chemistry88%Biochemistry86.8%Internal medicine81.2%Gene67.8%Cell biology45%Pathology44.9%Cancer research40.4%Cancer36.6%Immunology33.1%Endocrinology27.9%Bioinformatics23.7%Physics20.5%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

BIOCHEMISTRY & MOLECULAR BIOLOGY

Q1
Rank15/328
IndexSCIE
JCRSCIE2026

GENETICS & HEREDITY

Q1
Rank4/192
IndexSCIE
JCISCIE2026

BIOCHEMISTRY & MOLECULAR BIOLOGY

Q1
Rank21/328
IndexSCIE
JCISCIE2026

GENETICS & HEREDITY

Q1
Rank12/192
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF14.6
Articles / Year430
Total Citations69
2025
IF9.4
Articles / Year453
Total Citations1,018
2024
IF6.9
Articles / Year242
Total Citations1,330
2023
IF6.8
Articles / Year385
Total Citations4,942
2022
IF7.243
Articles / Year268
Total Citations7,141

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #1,790Scopus Q1SCImago Profile
Scopus Coverage:2014-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q1
1.776

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
6.05

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,627 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations5,087
3-Year Documents806
Citable Documents784

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate45.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

BiochemistryQ1
Cell BiologyQ1
Genetics (clinical)Q1
Molecular BiologyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2.9%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
1区BIOCHEMISTRY & MOLECULAR BIOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Genes & Diseases (acronym: gendis, abbr: GENES DIS, ISSN: 2352-4820) is a peer-reviewed international scholarly journal in the field of Multiple, published by ELSEVIER in China since 2014. The periodical holds a Journal Impact Factor (JIF) of 14.6, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.776 (Q1), an H-index of 77.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 110 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,627 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
ELSEVIER
Publication Language
English
Frequency
Quarterly
Founding Year
2014
Indexing & Databases
SCIEPubMed
Editorial Address
ELSEVIER, RADARWEG 29, AMSTERDAM, Netherlands, 1043 NX

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: e8bba3a9-d1fa-404d-a935-b30217ca414e
Database Updated: 2026-10-27